Transition report pursuant to Rule 13a-10 or 15d-10

Document and Entity Information

Document and Entity Information - USD ($)
6 Months Ended
Dec. 31, 2019
Mar. 26, 2020
Jun. 30, 2019
Document and Entity Information [Abstract]      
Entity Registrant Name RELMADA THERAPEUTICS, INC.    
Entity Central Index Key 0001553643    
Amendment Flag false    
Current Fiscal Year End Date --12-31    
Document Type 10-KT    
Document Period End Date Dec. 31, 2019    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2019    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Non-accelerated Filer    
Entity Shell Company false    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Public Float     $ 70,128,991
Entity Common Stock, Shares Outstanding   14,939,808  
Entity Interactive Data Current Yes    
Entity File Number 000-55347    
Entity Incorporation State Country Code NV